Targeting glycolysis: exploring a new frontier in glioblastoma therapy
Glioblastoma(GBM) is a highly malignant primary central nervous system tumor that poses a significant threat to patient survival due to its treatment resistance and rapid recurrence.Current treatment options, including maximal safe surgical resection, radiotherapy, and temozolomide (TMZ) chemotherap...
Saved in:
Main Authors: | Lu Yang, Sijia Li, Lei Yu, Jiao Leng, Na Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1522392/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical significance of HER2 in urothelial carcinoma and analysis of its correlation with glycolytic metabolic characteristics
by: Andong Guo, et al.
Published: (2024-12-01) -
Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects
by: Zhi-Xun Guo, et al.
Published: (2025-01-01) -
Elucidating the role of pyrimidine metabolism in prostate cancer and its therapeutic implications
by: Liang Huang, et al.
Published: (2025-01-01) -
Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma
by: Kai Wang, et al.
Published: (2025-02-01) -
Targeting lipid metabolism of macrophages: A new strategy for tumor therapy
by: Nan Shao, et al.
Published: (2025-02-01)